Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer

NCT00632268 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Gastric Cancer

Interventions

DRUG: RAD001; Cisplatin; 5-FU; Leucovorin

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]